Production of soluble CD34 by human myeloid cells.
CD34, a glycophosphoprotein present in lymphohaematopoietic stem and progenitor cells, as well as in other cell types, exists in both transmembrane and intracytoplasmic forms. Transmembrane CD34 expression, which is high in the earliest haematopoietic precursors, decreases as cells mature. However, to our knowledge, there is no information on whether a decrease in transmembrane CD34 can also predict a release of the molecule from the cell membrane into the extracellular fluid. To investigate the above possibility, we studied conditions (incubation time, cell density and proliferative status) in human myeloid cells (lines KG-1a, KG-1 and cord blood-derived cells) that may cause a decrease in surface CD34 and the generation of a soluble form of the molecule. The latter, as demonstrated by Western blot analysis, adds more complexity to the proposed structural features and functional properties of CD34 in myeloid cells.
Fernández
M
M
Unidad de Biología Celular, INTA, Universidad de Chile, and Laboratorio de Transplante de Médula Osea, Clínica Las Condes, Santiago, Chile. mfernand@uec.inta.uchile.cl
Simon
V
V
Minguell
J J
JJ
D018952:Antigens, CD34 / Q000276:immunology*; D015153:Blotting, Western; D002460:Cell Line; D002462:Cell Membrane / Q000276:immunology; D002470:Cell Survival; D005110:Extracellular Space / Q000276:immunology*; D005312:Fetal Blood / Q000166:cytology; D005434:Flow Cytometry; D006801:Humans; D007951:Leukemia, Myeloid / Q000276:immunology*
D018952:Antigens, CD34